💊 Biotech faces a crossroads of new technology and policy uncertainty, panelists said at an Axios Pro event ahead of the Milken Institute Global Conference. (Axios)
👀 The top publicly traded PE firms in the US haven't flinched in the face of tariff changes that rattled public markets and slowed M&A activity. (PitchBook)
🚢 Importers faced at least $417 million in new tariffs on shipments aboard one cargo shipcarrying an estimated $564 million in goods. (Bloomberg)
